Loading…
Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil
The aim of this study was to develop a nanostructured lipid carrier (NLC)-based hydrogel and study its potential for the topical delivery of 5-fluorouracil (5-FU). Precirol ATO 5 (glyceryl palmitostearate) and Labrasol were selected as the solid and liquid lipid phases, respectively. Poloxamer 188 a...
Saved in:
Published in: | International journal of nanomedicine 2016-01, Vol.11, p.5067-5077 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The aim of this study was to develop a nanostructured lipid carrier (NLC)-based hydrogel and study its potential for the topical delivery of 5-fluorouracil (5-FU). Precirol
ATO 5 (glyceryl palmitostearate) and Labrasol
were selected as the solid and liquid lipid phases, respectively. Poloxamer 188 and Solutol
HS15 (polyoxyl-15-hydroxystearate) were selected as surfactants. The developed lipid formulations were dispersed in 1% Carbopol
934 (poly[acrylic acid]) gel medium in order to maintain the topical application consistency. The average size, zeta potential, and polydispersity index for the 5-FU-NLC were found to be 208.32±8.21 nm, -21.82±0.40 mV, and 0.352±0.060, respectively. Transmission electron microscopy study revealed that 5-FU-NLC was |
---|---|
ISSN: | 1178-2013 1176-9114 1178-2013 |
DOI: | 10.2147/IJN.S117511 |